Craft

Tactile Medical

Stock Price

$14.5

2024-10-29

Market Capitalization

$346.8 M

2024-10-29

Revenue

$274.4 M

FY, 2023

Tactile Medical Summary

Company Summary

Overview
Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. The Company's offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinicians.
Type
Public
Status
Active
Founded
2006
HQ
Minneapolis, MN, US | view all locations
Website
http://www.tactilemedical.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • R. Jay Stracke

    R. Jay Stracke, Vice President of Reimbursement and Payer Relations

  • Darin J. Oenning

    Darin J. Oenning, VP Strategy and Business Development

  • Sunday J. Hoy

    Sunday J. Hoy, Vice President and Compliance Officer

    • Darren J. Wennen

      Darren J. Wennen, Senior Vice President, Commercial Operations

      LocationsView all

      1 location detected

      • Minneapolis, MN HQ

        United States

        3701 Wayzata Blvd #300

      Tactile Medical Financials

      Summary Financials

      Revenue (Q3, 2024)
      $73.1M
      Gross profit (Q3, 2024)
      $54.8M
      Net income (Q3, 2024)
      $5.2M
      Cash (Q3, 2024)
      $82.1M
      EBIT (Q3, 2024)
      $6.8M
      Enterprise value
      $294.6M

      Footer menu